Clinical trial Recruiting at 1 site Observational Ages 18 to 65

Bariatric Surgery and Gut Microbiota Changes Over Time

Official title: Longitudinal Evaluation of Gut Microbiota and Fecal Metabolome Following Roux-en-Y Gastric Bypass: Clinical Implications and Identification of Predictive Biomarkers

Run by Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis · NCT07381140 · Data updated 2026-11-12

This study looks at how gut bacteria and stool metabolites change over 12 months after Roux-en-Y gastric bypass in adults with obesity, compared with those treated with diet alone and healthy-weight individuals.

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment100 (estimated)
SponsorAzienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
Academic / other
Locations1 site (Castellana Grotte, BA)
StatusRecruiting
StartedJuly 7, 2026
Main results expectedApril 2027
Study endsApril 2028
Registry record updatedNovember 5, 2026
Trial IDNCT07381140 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 with obesity undergoing RYGB, or adults with obesity treated with diet alone, and healthy adults with normal weight.

Probably not a fit

Patients who are not undergoing bariatric surgery or do not fit the specified BMI or health criteria may not experience the suggested insights.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study will follow adults aged 18 to 65 who are undergoing Roux-en-Y gastric bypass, along with a control group of adults with obesity managed by diet and a healthy normal-weight group. Researchers will collect stool samples and blood at multiple time points over 12 months to analyze gut microbiota composition and fecal metabolome, and relate these findings to weight loss and metabolic outcomes. The goal is to understand the timing, persistence, and clinical relevance of microbial and metabolic changes after bariatric surgery compared with weight-loss by diet alone and with normal weight. The study does not involve an intervention beyond standard clinical care and data collection, and eligibility is limited to specified BMI ranges and health statuses. Interventions are not specified beyond observational data collection.

Why it matters

Potential benefit: If successful, the study could clarify how bariatric surgery reshapes the gut ecosystem and whether these changes relate to improved metabolic health.

How similar studies have gone: Previous observational work suggests gut microbiota can change after bariatric procedures, but longitudinal links to clinical outcomes remain to be clarified in this comparator design.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria (RYGB Group):

* Age between 18 and 65 years.
* Adults with a body mass index (BMI) ≥ 35 kg/m² with related comorbidities, or BMI ≥ 40 kg/m², who are candidates for Roux-en-Y gastric bypass (RYGB) surgery only.

Exclusion Criteria (RYGB Group):

* Treatment with antibiotics within the last 3 weeks, or probiotics/prebiotics within the last 4-6 weeks, or systemic corticosteroids within the 8 weeks prior to baseline (T0).
* Participation in dietary regimens or calorie restriction programs in the weeks prior to enrollment.
* Chronic inflammatory bowel diseases (e.g., Crohn's disease, ulcerative colitis), ongoing enteric infections, or active neoplasms.
* Previous organ transplant or ongoing systemic immunosuppressive therapy.
* Pregnancy or breastfeeding.
* Previous major gastrointestinal surgery.
* Chronic alcohol consumption above moderate levels or substance use disorder.

Inclusion Criteria (Obese Control Group):

* Age between 18 and 65 years.
* Adults with BMI ≥ 30 kg/m² who are candidates for structured dietary treatment.

Inclusion Criteria (Healthy Control Group):

* Age between 18 and 65 years.
* Normal weight (BMI between 18.5 and 24.9 kg/m²).
* Normal metabolic function: fasting glucose below threshold, normal ALT/AST, no diagnosis of diabetes or metabolic syndrome.
* No chronic gastrointestinal diseases or conditions that could alter the gut microbiota.

Exclusion Criteria (Obese Control and Healthy Control Group):

* Use of antibiotics within the last 3 weeks or probiotics/prebiotics within the last 4-6 weeks.
* Recent gastrointestinal surgery.
* Pregnancy or breastfeeding.
* Extreme diets or recent dietary changes.
* Recent international travel that could have affected the gut microbiota.
* Medications known to influence the gut microbiota (e.g., PPIs, metformin, steroids).
* Active smoking or excessive alcohol consumption.
* Significant gastrointestinal symptoms (chronic diarrhea or constipation).

Where it's running

  • Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
    Castellana Grotte, Ba, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.